awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36245315-D45BEBFE-11DE-448D-B12A-D4D1E492A36B
Q36245315-D45BEBFE-11DE-448D-B12A-D4D1E492A36B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36245315-D45BEBFE-11DE-448D-B12A-D4D1E492A36B
BOLERO-2 - will this change practice in advanced breast cancer?
P2860
Q36245315-D45BEBFE-11DE-448D-B12A-D4D1E492A36B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36245315-D45BEBFE-11DE-448D-B12A-D4D1E492A36B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7743c86a513ab9dd4a40834f39652f1a813f38c0
P2860
Gefitinib or placebo in combination with tamoxifen in patients with hormone receptor-positive metastatic breast cancer: a randomized phase II study.